National Cancer Institute
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
Deadline
November 10, 2026
Eligibility
Global, Foreign organizations eligible, Kenya
Funding Amount
Unlock to view
Grant Overview
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) is a research funding opportunity offered by National Cancer Institute covering areas such as Cancer, Biomedical Technology, Diagnostics, Clinical Research for applicants in Global, Foreign organizations eligible, Kenya. The application deadline is November 10, 2026.
Researchers, universities, institutions and eligible organizations should review the funder requirements, geographic eligibility, research focus and deadline before preparing an application.
Focus Areas
Geographic Eligibility
- •Global
- •Foreign organizations eligible
- •Kenya
Before You Apply
Confirm the final deadline, applicant requirements, funding conditions and submission instructions on the official funder website before submitting an application.